Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...
Главные авторы: | Pellagatti, A, Boultwood, J |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Elsevier
2016
|
Схожие документы
-
Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
по: Armstrong, R, и др.
Опубликовано: (2017) -
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
по: Boultwood, J, и др.
Опубликовано: (2014) -
Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
по: Pellagatti, A, и др.
Опубликовано: (2017) -
Gene expression profiling in the myelodysplastic syndromes.
по: Pellagatti, A, и др.
Опубликовано: (2005) -
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
по: Johanna Flach, и др.
Опубликовано: (2020-09-01)